named programs · 3 · from sources
What they call their work
Clinical Trial Management Platform
Digital infrastructure to support clinical trials for Investigational New Drug development
Drug Supply Chain Security Hyperledger
Blockchain-based system to ensure security and traceability in the distribution of Ibogaine and related compounds
Ibogaine Endabuse(R)
Anti-addiction product development program focused on Ibogaine for opioid and substance use disorder treatment
activities · 2 groups
What they do
-
Biomedical Research and Innovation 1 activity
- Prepares Drug Master Files and supports public-private partnerships for drug developmentPrepares Drug Master Files for Ibogaine Endabuse(R) and Tabernanthe Iboga/Voacanaga Iboga, including intellectual property provisions, to enable public-private partnerships focused on health equity, clinical trial management, and secure drug supply chains using blockchain technology.
-
-
Uncategorized 1 activity
- Conducts drug research for neglected diseases and mental health with focus on IbogaineConducts research on Ibogaine as an antiaddiction product in preparation for FDA Investigational New Drug application development, specifically for an opioid abatement program in New York State.
-
financials · form 990EZ · fy2022
revenue
Total revenue$90K
Contributions & grants$70K78%
Program service revenue$00%
Investment income$00%
Other revenue$7K
expenses
Total expenses$44K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits$2K
Grants paid out$0
balance sheet
Total assets$73K
Cash—
Investments—
Liabilities—
Net assets$60K
1 years on record · 2022–2022
leadership · form 990 part vii · fy2022
Who runs it
board members · 3
- Agostino von Hassell — Veterans Program Director
- Andres S Cordova — Media director
- Gene Weiss — director
relationships · 1
Who they work with
- FDA Government — Engages with the FDA in preparation for Investigational New Drug development for opioid abatement.
strategies · 2
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Blockchain-Enabled Health Equity Infrastructure 320 orgsmethodology: public-private-partnership-for-health-equityBy securing intellectual property and drug supply chains using blockchain-based hyperledger technology, we promote health equity and accessibility, because transparent and tamper-proof systems enable trustworthy public-private partnerships and ensure equitable access to emerging treatments.shared approach: Venture Philanthropy Model →
- Regulatory Pathway Development for Novel Therapeutics 320 orgsmethodology: regulatory-pathway-developmentBy advancing Ibogaine through regulatory preparation toward FDA Investigational New Drug status, we enable clinical adoption of antiaddiction treatments, because establishing a clear regulatory pathway de-risks development for public and private stakeholders and unlocks access to rigorous clinical evaluation.shared approach: Venture Philanthropy Model →